At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Oxytrol Transdermal System Actual Use Study (Consumer Trial of Oxytrol, Control)
In Brief
A Phase 3 clinical trial evaluating Oxybutynin (Oxytrol, BAY839380) for Overactive Bladder. Completed, enrolled 855 participants across 1 site.
Detailed Summary
With this study researchers want to gather information about the consumer use behavior of Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a prescription from a healthcare professional. An area of focus was on the potential benefits of an over-the-counter status for Oxytrol and on the ongoing use behavior of the consumers. Oxytrol is a thin, flexible, clear patch that is indicated for the treatment of overactive bladder a disease characterized by a collection of symptoms, including urinary frequency, urgency, and urge incontinence. The adhesive patch is placed on the skin to deliver Oxytrol through the skin into the bloodstream.
Study Details
Timeline
Interventions
Oxybutynin transdermal patch, 3.9 mg daily (Oxytrol Transdermal System)